NPPB and hydrops fetalis: In addition, we found higher NT-proBNP levels among patients with AF for all time points through 2 years of study follow-up and actually an increase in this biomarker after 6 months for those with AF compared with a decrease among those without AF despite ongoing efforts at HF medical therapy optimization.